Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer-Reference-Cited by-同舟云学术

Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer

Published:2023-11 Issue: Volume:178 Page:89-95
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

McLaughlin Hannah D.,Greco Patricia,Straubhar Alli M.,Rolston Aimee,McCool Kevin,Brackmann Melissa,Siedel Jean H.,McLean Karen,Reynolds R. Kevin,Uppal Shitanshu

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference35 articles.

1. Prognosis of cancers associated with venous thromboembolism;Sørensen;N. Engl. J. Med.,2000

2. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy;Khorana;J. Thromb. Haemost.,2007

3. Thrombosis in ovarian cancer: a case control study;Metcalf;Br. J. Cancer,2014

4. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?;Shafa;Gynecol. Oncol.,2023

5. Incidence and timing of thromboembolic events in patients with ovarian cancer undergoing neoadjuvant chemotherapy;Greco;Obstet. Gynecol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis;International Journal of Gynecologic Cancer;2024-03-01

2. Ovarialkarzinom: Thromboseprophylaxe während der neoadjuvanten Chemotherapie;Geburtshilfe und Frauenheilkunde;2024-02

3. Research Progress on Risk Factors and Risk Assessment Models for VTE in Malignant Tumor Patients;Advances in Clinical Medicine;2024